Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1989; Volume 36,Issue 1
  • You have access
    Evidence for a pulmonary B3 bradykinin receptor.
    S G Farmer, R M Burch, S A Meeker and D E Wilkins
    Molecular Pharmacology July 1989, 36 (1) 1-8;
  • You have access
    Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
    J P Sommadossi, R Carlisle and Z Zhou
    Molecular Pharmacology July 1989, 36 (1) 9-14;
  • You have access
    Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
    J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron
    Molecular Pharmacology July 1989, 36 (1) 15-21;
  • You have access
    Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    J A Moscow, A J Townsend and K H Cowan
    Molecular Pharmacology July 1989, 36 (1) 22-28;
  • You have access
    Immunological characterization of human phenol sulfotransferase.
    J A Heroux, C N Falany and J A Roth
    Molecular Pharmacology July 1989, 36 (1) 29-33;
  • You have access
    Development of a photoaffinity ligand for octopamine receptors.
    J A Nathanson
    Molecular Pharmacology July 1989, 36 (1) 34-43;
  • You have access
    Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells.
    F Gusovsky, T Yasumoto and J W Daly
    Molecular Pharmacology July 1989, 36 (1) 44-53;
  • You have access
    Characterization and quantitation of monoamine oxidases A and B in mitochondria from human placenta.
    L A Riley, M A Waguespack and R M Denney
    Molecular Pharmacology July 1989, 36 (1) 54-60;
  • You have access
    Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes.
    T D Porter, S C Khani and M J Coon
    Molecular Pharmacology July 1989, 36 (1) 61-65;
  • You have access
    The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene.
    L C Quattrochi and R H Tukey
    Molecular Pharmacology July 1989, 36 (1) 66-71;
  • You have access
    Selective parasympathectomy increases the quantity of inhibitory guanine nucleotide-binding proteins in canine cardiac ventricle.
    T D Hodges, J C Bailey, J W Fleming and R J Kovacs
    Molecular Pharmacology July 1989, 36 (1) 72-77;
  • You have access
    Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
    S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng
    Molecular Pharmacology July 1989, 36 (1) 78-82;
  • You have access
    Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
    S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez
    Molecular Pharmacology July 1989, 36 (1) 83-88;
  • You have access
    Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
    T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer
    Molecular Pharmacology July 1989, 36 (1) 89-96;
  • You have access
    Identification of a polymorphically expressed member of the human cytochrome P-450III family.
    S A Wrighton, B J Ring, P B Watkins and M VandenBranden
    Molecular Pharmacology July 1989, 36 (1) 97-105;
  • You have access
    Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
    H Manev, M Favaron, A Guidotti and E Costa
    Molecular Pharmacology July 1989, 36 (1) 106-112;
  • You have access
    [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.
    A Poland, P Teitelbaum and E Glover
    Molecular Pharmacology July 1989, 36 (1) 113-120;
  • You have access
    Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
    A Poland, P Teitelbaum, E Glover and A Kende
    Molecular Pharmacology July 1989, 36 (1) 121-127;
  • You have access
    Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
    M J Pallardy, R V House and J H Dean
    Molecular Pharmacology July 1989, 36 (1) 128-133;
  • You have access
    Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells.
    W P Gati and A R Paterson
    Molecular Pharmacology July 1989, 36 (1) 134-141;
  • You have access
    Thrombin and trypsin act at the same site to stimulate phosphoinositide hydrolysis and calcium mobilization.
    L G Jones, P M McDonough and J H Brown
    Molecular Pharmacology July 1989, 36 (1) 142-149;
  • You have access
    Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
    R J Hill, H J Duff and R S Sheldon
    Molecular Pharmacology July 1989, 36 (1) 150-159;
  • You have access
    Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate.
    M A Sills and P S Loo
    Molecular Pharmacology July 1989, 36 (1) 160-165;
  • You have access
    Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.
    G Tsujimoto, A Tsujimoto, E Suzuki and K Hashimoto
    Molecular Pharmacology July 1989, 36 (1) 166-176;
  • You have access
    Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
    C E Spivak, J A Waters and R S Aronstam
    Molecular Pharmacology July 1989, 36 (1) 177-184;
  • You have access
    Permeation and salvage of dideoxyadenosine in mammalian cells.
    P G Plagemann and C Woffendin
    Molecular Pharmacology July 1989, 36 (1) 185-192;
  • You have access
    Dissociation of the accumulation of single-strand breaks in DNA from the killing of cultured hepatocytes by an oxidative stress.
    J B Coleman, D Gilfor and J L Farber
    Molecular Pharmacology July 1989, 36 (1) 193-200;
  • You have access
    Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    M A Riva and I Creese
    Molecular Pharmacology July 1989, 36 (1) 201-210;
  • You have access
    Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    M A Riva and I Creese
    Molecular Pharmacology July 1989, 36 (1) 211-218;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 36, Issue 1
1 Jul 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics